Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 1
2016 1
2017 1
2019 1
2020 1
2021 1
2022 2
2023 1
2024 1
2025 5
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Radiation and Melanoma: Where Are We Now?
Bliley R, Avant A, Medina TM, Lanning RM. Bliley R, et al. Among authors: medina tm. Curr Oncol Rep. 2024 Aug;26(8):904-914. doi: 10.1007/s11912-024-01557-y. Epub 2024 Jun 1. Curr Oncol Rep. 2024. PMID: 38822928 Review.
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts.
Morton JJ, Ramos SA, Alzofon N, Keysar SB, Armitage LH, Baker AS, Barra JM, Chimed TS, Le PN, Nieto C, Weaver AN, Thomas CM, Miller B, Robinson W, Medina TM, Gao D, Russ HA, Jimeno A. Morton JJ, et al. Among authors: medina tm. Cancer Res Commun. 2025 Nov 1;5(11):2053-2065. doi: 10.1158/2767-9764.CRC-25-0357. Cancer Res Commun. 2025. PMID: 41129601 Free PMC article.
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors.
Milhem MM, Wise-Draper TM, Chandra S, Hanna GJ, Laux DE, Medina TM, Ansstas G, Daud A, Kelly CM, O'Day SJ, Perez CA, Wong MK, Friedlander PA, Kristedja TS, Burgess MA, Cowey CL, Hanks BA, Weight RM, Daniel WL, Feltner DE, Mix S, Sindelar L, Bexon AS, Bexon MF, Michel RE, Bhatia S. Milhem MM, et al. Among authors: medina tm. J Immunother Cancer. 2025 Jul 25;13(7):e011651. doi: 10.1136/jitc-2025-011651. J Immunother Cancer. 2025. PMID: 40713179 Free PMC article. Clinical Trial.
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.
Tobin RP, Cogswell DT, Cates VM, Davis DM, Borgers JSW, Van Gulick RJ, Katsnelson E, Couts KL, Jordan KR, Gao D, Davila E, Medina TM, Lewis KD, Gonzalez R, McFarland RW, Robinson WA, McCarter MD. Tobin RP, et al. Among authors: medina tm. Clin Cancer Res. 2023 Apr 3;29(7):1209-1219. doi: 10.1158/1078-0432.CCR-22-2495. Clin Cancer Res. 2023. PMID: 36378549 Free PMC article.
Decitabine reverses innate immune gene suppression in rare melanomas.
MacBeth ML, Bagby SM, Borgers JSW, Turner JA, Anderson KC, Whitty PA, Hartman S, Yacob B, Rebecca VW, Davila E, Pitts TM, Medina TM, Patel SP, McCarter MD, Robinson WA, Tobin RP, Couts KL. MacBeth ML, et al. Among authors: medina tm. bioRxiv [Preprint]. 2025 Aug 28:2025.08.24.671992. doi: 10.1101/2025.08.24.671992. bioRxiv. 2025. Update in: Mol Cancer Ther. 2026 Jul 14. doi: 10.1158/1535-7163.MCT-25-1325. PMID: 40909489 Free PMC article. Updated. Preprint.
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study.
Lorigan P, Medina TM, Nyakas M, Rutten A, Feun LG, Cowey CL, Payne M, Hussain I, Kuzel T, O'Day S, Sheri A, Friedlander PA, Kumar S, Bergersen VS, Foss Ø, Ellingsen EB, Bjørheim J, Bechter OE. Lorigan P, et al. Among authors: medina tm. Eur J Cancer. 2026 Jan 17;233:116162. doi: 10.1016/j.ejca.2025.116162. Epub 2025 Dec 3. Eur J Cancer. 2026. PMID: 41365069 Clinical Trial.
Decitabine reverses innate immune gene suppression in rare melanomas.
MacBeth ML, Bagby SM, Borgers JSW, Turner JA, Anderson K, Whitty PA, Hartman SJ, Yacob B, Rebecca VW, Davila E, Pitts TM, Medina TM, Patel SP, McCarter MD, Robinson WA, Tobin RP, Couts KL. MacBeth ML, et al. Among authors: medina tm. Mol Cancer Ther. 2026 Jul 14. doi: 10.1158/1535-7163.MCT-25-1325. Online ahead of print. Mol Cancer Ther. 2026. PMID: 42442347
19 results